ADD Medication Study- Conditions:
ADD/ADHD,
Disabilities: Intellectual,
Medications
- Gender:
Female,
Male
Researchers at Cincinnati Children’s Hospital Medical Center are conducting a research study, sometimes known as a clinical trial or clinical study, to study response to medication in children with Attention Deficit Disorder (ADD). During the study, children undergo a full diagnostic evaluation for...
More
ADHD Research Study- Conditions:
ADD/ADHD,
Disabilities: Intellectual,
Medications,
Neurology
- Gender:
Female,
Male
University of Cincinnati (UC) and Cincinnati Children’s Hospital Medical Center (CCHMC) are conducting a research study to better understand the how the brain works in children with Attention Deficit Hyperactivity Disorder (ADHD). We are also interested in understanding how an ADHD medication calle...
More
Marfan Syndrome (MFS) Medication Study- Conditions:
Adult Studies,
Cardiology/Heart,
Medications
- Gender:
Female,
Male
This study will compare the effect of beta blocker therapy (Atenolol) to that of angiotensin II receptor blocker therapy (Losartan) on the rates of aortic growth and other cardiovascular outcomes....
More
Medication Study For Children Having Heart Surgery- Conditions:
Cardiology/Heart,
Medications
- Gender:
Female,
Male
This study will determine if intravenous citrulline given during cardiac surgery lowers the risk of high blood pressure in the lungs in children undergoing certain surgeries for repair of congenital heart problems. ...
More
Intravenous Mepolizumab for Eosinophilic Esophagitis- Conditions:
Eosinophilic Disorders,
Gastroenterology, Hepatology and Nutrition,
Medications
- Gender:
Female,
Male
The Cincinnati Center for Eosinophilic Disorders at Cincinnati Children's Hospital Medical Center is currently conducting a randomized, double-blind, parallel group clinical trial of intravenous mepolizumab. This study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of...
More
Anti-IL-5 Open-Label Study for Hypereosinophilic Syndrome- Conditions:
Eosinophilic Disorders,
Medications
- Gender:
Female,
Male
GSK will sponsor this compassionate use trial of mepolizumab to treat subjects with HES who have significant clinical disease due to HES, are unresponsive to medication used to treat HES and those who have demonstrated clinical benefit with previous anti IL-5 treatment. The overall objective of thi...
More
Fluticasone Propionate (FP) Treatment- Conditions:
Eosinophilic Disorders,
Medications
- Gender:
Female,
Male
The Cincinnati Center for Eosinophilic Disorders at Cincinnati Children's Hospital Medical Center is currently conducting a double blinded, randomized trial of swallowed 1760mcg Fluticasone propionate (FP) versus placebo in the treatment of Eosinophilic Esophagitis. The purpose of this study is to ...
More
Familial Adenomatous Polyposis (FAP) Research: Children/ Teens- Conditions:
Gastroenterology, Hepatology and Nutrition,
Medications,
Other
- Gender:
Female,
Male
Cincinnati Children’s is conducting a research study, sometimes known as a clinical study or trial, to test the effect and safety of the study drug celecoxib for the treatment of familial adenomatous polyposis (FAP) in children and teens. The study will help determine if the study drug can stablili...
More
Other Current Clinical Studies- Conditions:
Adult Studies,
Eosinophilic Disorders,
Medications,
Urology,
Other
- Gender:
Female,
Male
Members of the Division of Gastroenterology, Hepatology and Nutrition at Cincinnati Children's Hospital Medical Center have a large number of active clinical studies which are listed on this page. William F. Balistreri, MDPegylated Interferon +/— Ribavirin for Children with HCVCCHMC IRB# 04-2-31Typ...
More
Ovary Protection Medication Study for Childhood Onset Lupus - Conditions:
Adult Studies,
Autoimmune,
Lupus,
Medications,
Rheumatology
- Gender:
Female
To determine the safety and effectiveness of an ovary protection medication (triptorelin), and its dosage and the time necessary to suppress ovaries to protect them against harmful effects of chemotherapy used in treating lupus....
More